Hjem
Rolf Bjerkvigs bilde

Rolf Bjerkvig

Professor
  • E-postRolf.Bjerkvig@uib.no
  • Telefon+47 55 58 63 52+47 951 18 268
  • Besøksadresse
    Jonas Lies vei 91
  • Postadresse
    Postboks 7804
    5020 Bergen

Rolf Bjerkvig (f. 1953) er professor for cellebiologi og har siden 80tallet jobbet i eksperimentell kreftbiologi.

I 2015 ble Bjerkvig tildelt kong Olav V kreftforskningsprisen.

 

 

OD1ANA - Anatomi

MEDOD1, MEDOD2

MEIBM900

FARM260 - Molekylær cellebiologi

BMED330 - Cellekommunikasjon

BMED331 - Tumorbiologi

 

  • Vis forfatter(e) 2020. Tumor-penetrating peptide for systemic targeting of Tenascin-C. Scientific Reports.
  • Vis forfatter(e) 2020. Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects. Neuro-Oncology Advances (NOA).
  • Vis forfatter(e) 2020. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. 1-31.
  • Vis forfatter(e) 2020. Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection. Cancers.
  • Vis forfatter(e) 2020. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications.
  • Vis forfatter(e) 2019. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. EMBO Molecular Medicine.
  • Vis forfatter(e) 2019. Peptide-guided nanoparticles for glioblastoma targeting. Journal of Controlled Release. 109-118.
  • Vis forfatter(e) 2019. Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-kappa B Signaling. Clinical Cancer Research. 6868-6881.
  • Vis forfatter(e) 2019. Improved drug delivery to brain metastases by peptide-mediated permeabilization of the blood-brain barrier. Molecular Cancer Therapeutics. 2171-2181.
  • Vis forfatter(e) 2019. Effective treatment of metastatic melanoma by combining mapk and pi3k signaling pathway inhibitors. International Journal of Molecular Sciences. 1-19.

Se fullstendig oversikt over publikasjoner i CRIStin.

1987: Dr. philos. The Gade Institute of Pathology, University of Bergen

1981: M.Sc. Immunology, University of San Francisco, 1981.